
View larger version (32K):
[in a new window]
|
Fig. 2. (A) Western blot of T7-VSG 117 (wild-type VSG 117 expressed in the same
context as the mutants) compared with mutants S505G, S505A, S505T, K510R and
K510L. The cells were induced with 100 ng/ml doxycycline for 24 hours, and the
equivalent of 2x104 cells were loaded per lane. (B,C) Western
blots of cell line T7-VSG 117 after endogenous GPIPLC activation. Aliquots
representing 2x104 cells were loaded per lane. Cells
coexpressing VSGs 117 and 221 were osmotically lysed in ice-cold water and
centrifuged. The cell ghosts (P1) were resuspended and incubated in 10 mM
sodium phosphate buffer, pH 8.0, at 37°C for 15 minutes and centrifuged to
generate pellet (P2) and supernatant (S) fractions. Lanes C, P1, P2 and S
contain, respectively, whole cells, pellet after lysis and pellet and
supernatant after GPIPLC activation. (B) VSG 117 release in the absence or
presence of 5 mM pCMPS during PIPLC cleavage, probed with antibodies to VSG
117. (C) Analysis of the same samples, in the absence of pCMPS, with anti-VSG
221 antibodies. (D) Analysis with anti-BiP antibodies. (E) The same protocol
was applied to a GPIPLC null-mutant cell line expressing VSG 221
(Leal et al., 2001 ) and the
blot was probed with VSG 221 antibodies.
|